Trial intelligence / Profile preview

Pyrotinib combined with standard treatment for previously untreated HER2-positive breast cancer brain metastases

ChiCTR1900020670Phase 4Not yet recruiting

Sponsor

Harbin Medical University Cancer Hospital

Start

Mar 2019

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1